Sean George Biography and Net Worth

CEO of Invitae

Sean is chief executive officer of Invitae, whose mission is to bring genetic information into mainstream medicine. Prior to his CEO position, he served as Invitae’s president and chief operating officer. Sean was a co-founder and CEO of Locus Development, an early stage genetic analysis startup that later merged with Invitae. Prior to co-founding Locus, he served as COO at Navigenics, an early leader in personalized medicine. Previously, he has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen. In the past, he has also worked at McKinsey & Co. and Molecular Probes. Dr. George holds a B.S. in Molecular Genetics from UCLA, an M.S. in Molecular Biology from UC Santa Barbara, and a Ph.D. in Molecular Genetics from UC Santa Cruz.

What is Sean E. George's net worth?: The estimated net worth of Sean E. George is at least $219.80 as of December 19th, 2022. Dr. George owns 732,677 shares of Invitae stock worth more than $220 as of December 22nd. This net worth evaluation does not reflect any other assets that Dr. George may own. Learn More about Sean E. George's net worth.
How do I contact Sean E. George?: The corporate mailing address for Dr. George and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (628) 213-3369 and via email at [email protected]. Learn More on Sean E. George's contact information.
Has Sean E. George been buying or selling shares of Invitae?: Sean E. George has not been actively trading shares of Invitae during the past quarter. Learn More on Sean E. George's trading history.
Who are Invitae's active insiders?: Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.

Sean E. George Insider Trading History at Invitae

Sean E. George Buying and Selling Activity at Invitae

Invitae Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Today's Range

Now: $0.00

$0.00

50 Day Range

MA: N/A

2 Week Range

Now: $0.00

$0.02

Volume

75 shs

Average Volume

23,716,614 shs

Market Capitalization

$80,103.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

The #1 Coin for November 2024

From Crypto 101 Media | Ad

You can get access to the report by clicking here now…